Comenius University in Bratislava (UNIBA)

Comenius University in Bratislava is a research institution that runs hundreds of domestic and international research projects. A representative of the Pharmaceutical Faculty at Comenius University in Bratislava was a member of the Reimbursement Committee for Medicinal products of the Slovak Ministry of Health on behalf of the Union Health Insurance Fund.

Role in the project: UNIBA provides expertise in medical devices and in reimbursement for the project.

Gesundheit Österreich GmbH (GOEG)

The Austrian National Public Health Institute (Gesundheit Österreich GmbH) is the institution responsible for researching and planning public healthcare in Austria. It also acts as the national competence and funding centre for health promotion and prevention and facilitates healthcare-related research. GOEG is a public, non-profit limited liability company wholly owned by the Republic of Austria, represented by the Federal Ministry of Social Affairs, Health, Care and Consumer Protection.

Role in the project: GOEG provides expertise in medicines pricing, pricing and reimbursement policies for pharmaceuticals and medical devices, and in comparative pharmaceutical systems research. Due to its collaboration with policymakers GOEG also contributes to information-sharing and cross-country collaboration in the project.

Universitetet i Oslo

Universitetet i Oslo is Norway’s largest and oldest university. The university has 27 700 students and 6 000 employees. The university consists of five faculties that conduct research and provide teaching in theology, law, medicine, humanities, mathematics and natural sciences, odontology, social sciences and social sciences. The Faculty of Medicine’s core activities are research, education, dissemination and innovation for the best of patients and society.

Role in the project: UIO contributes in the use cases precision cancer medicines and medical devices, and with expertise in HTA, mathematic simulation modelling, priority settings and register data analyses.

The International Association of Mutual Benefit Societies (AIM)

AIM serves as the international umbrella organization for federations of health mutuals and statutory and complementary health insurance bodies.
The work of its members is based on solidarity, not for profit work and democracy across Europe, Latin America, Africa, and the Middle East.
AIM advocates for equal access to health and care, fair pricing of medicines, a digitalisation that serves the insured, the integration of health in all policies and a stronger focus on prevention.

Role in the project: The innovative algorithm combining affordability and support to valuable innovation will be the base for the innovative pricing model in ASCERTAIN.

European Hematology Association

European Hematology Association (EHA) – EHA is a non-governmental and non-profit membership organization guided by its mission to promote excellence in patient care, research, and education in haematology. EHA is the largest Europe-based organization that brings together medical professionals, researchers and scientists with an interest in haematology. EHA represents hematology and hematologists in the European political and policy arena to improve regulation, increase the availability and affordability of medicines, and harmonize the education and training of hematologists.

Role in the project: contributes expertise in pricing and cost-effectiveness in project.

Chino.io (CHINO)

Chino SRL is an Italian cyber security and cloud technology company founded in 2014 with the mission of helping health application developers solve security and privacy law compliance issues when dealing with health sensitive data in the cloud. Chino SRL has created a software development platform called Chino.io. The platform offers developers a set of APIs to store, share and manage sensitive health data securely and fully comply with all data protection laws, including GDPR, ePrivacy and HIPAA.

Role in the project: Data management & ethics in WP2.

Myeloma Patients Europe (MPE)

Myeloma Patients Europe (MPE) is an umbrella organisation of myeloma and AL amyloidosis patient groups across Europe. MPE currently has 53 members based in 33 countries. The mission of the organisation is to provide education, information, and support to member groups and to advocate at European, national, and local levels for the best possible research and equal access to treatment and care. To achieve its aims, MPE works directly with members, healthcare professionals, reimbursement authorities, regulators, politicians, pharmaceutical companies, and the media to ensure all stakeholders collaborate to improve patient outcomes and reduce inequalities across Europe.

Role in the project: patient engagement, identifying patient needs and preferences for models’ development.

OptiMedis AG (OM)

OptiMedis is a management and health data analytics company registered in Germany. Its core business is developing and managing regional integrated care delivery systems with physician networks and other providers. OptiMedis´ approach to transforming health care systems has frequently been recognised by the EU, multiple EU research projects, the Commonwealth Fund, Duke Margolis Centre for Health Policy, WHO, the World Bank and others. OptiMedis manages three Integrated Care Delivery Systems in Germany with a population of over 120,000 and involving over 150 health care providers. OptiMedis is currently involved in competitive research and implementation projects with a volume of over 10 million Euros.

Role in the project: Dissemination and exploitation activities of the project, green manufacturing of health technology.